Integrated Environmental Technologies, Ltd. Announces MRSA - Specific EPA Registration Of EcaFlo(R) Excelyte(R)
Main Category: MRSA / Drug ResistanceAlso Included In: Infectious Diseases / Bacteria / Viruses
Article Date: 29 Apr 2009 - 7:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
3 (1 votes) |
Integrated Environmental Technologies, Ltd. (OTCBB: IEVM) and Benchmark Research & Technology (BRT) announced that the U.S. EPA has approved EcaFlo® Anolyte (trademarked Excelyte®), as a registered and effective biocide against MRSA (Methicillin-Resistant Staphylococcus Aureus), one of the most prolific and feared bacterial infections facing the public today. Today's announcement comes only a few months after the EPA approved EcaFlo® Excelyte® as a high-level disinfectant/biocide.
Since gaining EPA registration, Excelyte® has quickly gained momentum and is fast becoming the microbiocide of choice for hospitals, universities, public school systems, medical and veterinary schools , cleaning services, food processing, athletic departments, veterinary clinics, medical research labs, state, county, city and federal governments and professional sports teams. Excelyte® is the choice for these entities because MRSA and other bacterial threats are more than just a hospital problem. Excelyte® is a non-toxic, and yet exceptionally strong, oxidizing solution that destroys MRSA, E. coli, Salmonella, Hepatitis C, TB and almost every other pathogen in a manner that prevents them from mutating and thereby preventing the development of new resistant microorganisms.
South Carolina-based IET specializes in the manufacturing and production of the EcaFlo® system, the only system in the U.S. producing an EPA registered anolyte solution (Excelyte®). William E. Prince, President and CEO of IET said, "The U.S. Environmental Protection Agency has considered the MRSA-specific research results we submitted, and has determined it is indeed effective in destroying MRSA. We believe that EcaFlo® Excelyte® is the most effective biocide in the world today. IET is committed to working with its clients and partners to further inform the public on the multitude of applications for the product. We believe Excelyte® revolutionizes the way we currently disinfect to prevent the spread of MRSA and other bugs."
Due to the non-toxic nature of Excelyte® and proven research supporting its efficacy against MRSA and other bacteria, University General Hospital in Houston, Texas announced that it would be the first hospital in the country to implement Excelyte® as its disinfecting agent. Excelyte® was donated to help in the disaster clean-up and restoration efforts following Hurricane Ike and many school systems and county governments in the Carolinas are making the change to Excelyte®.
Source
Benchmark Research & Technology
Visit our mrsa / drug resistance section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/148145.php>
APA
http://www.medicalnewstoday.com/releases/148145.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




